Droopy eyelid surgery may boost vision and confidence, new study hopes to prove
NCT ID NCT07534436
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 73 people with congenital ptosis (droopy eyelids) who are already scheduled for a specific surgery. Researchers will check their vision and ask about their quality of life before surgery and at 1, 3, and 6 months after. The goal is to see if the surgery improves eyesight and emotional well-being.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Levator Resection combined with Fascial Sheath Suspension surgery
- What this could lead to
- If successful, this study could show that this combined surgery improves vision and quality of life for people with congenital ptosis.
- What could go wrong
- This is a small observational study (73 people) with no control group, so results may not apply to everyone. It only tracks outcomes for 6 months, so long-term effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 73 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The plan is to continuously enroll newly diagnosed or unoperated patients from the Ophthalmic Plastic Surgery Clinic of the Sun Yat-sen University Eye Center, and simultaneously invite accompanying individuals as a control group
- Ages
-
3 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Unilateral or bilateral congenital ptosis, male or female; 2. Age: 3-60 years old 3. Informed consent, and voluntary signing of the informed consent form, in compliance with ethical norms Exclusion Criteria: \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Congenital ptosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Zhongshan Ophthalmic Center
RECRUITINGGuangzhou, Guangdong, 510000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.